Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;54(1):81-4.
doi: 10.1007/s10384-009-0756-6. Epub 2010 Feb 12.

Elevation of surfactant protein D, a pulmonary disease biomarker, in the sera of uveitis patients with sarcoidosis

Affiliations

Elevation of surfactant protein D, a pulmonary disease biomarker, in the sera of uveitis patients with sarcoidosis

Nobuyoshi Kitaichi et al. Jpn J Ophthalmol. 2010 Jan.

Abstract

Purpose: Surfactant protein D (SP-D) is found in the epithelial cells of multiple mucosal surfaces. It is commonly used to diagnose and screen for pulmonary diseases. In the present study, serum levels of SP-D were measured in patients with uveitis to ascertain whether SP-D is a clinically useful laboratory parameter to diagnose sarcoidosis.

Methods: Sera were obtained from 81 patients with sarcoidosis, 16 patients with Behçet disease, 40 patients with HLA-B27 associated uveitis, 50 patients with Vogt-Koyanagi-Harada (VKH) disease, and 33 healthy volunteers. Serum SP-D levels were quantified with an SP-D enzyme immunoassay kit.

Results: In the healthy control subjects, the average serum SP-D level was 39.70 ng/ml; in the uveitis patients with sarcoidosis, the mean serum SP-D level was 57.0 ng/ml, and in the uveitis patients with other etiologies the mean levels were 38.63 ng/ml for Behçet disease, 38.18 ng/ml for HLA-B27 associated uveitis, and 31.32 ng/ml for the VKH patients. The average serum SP-D levels of patients with sarcoidosis were significantly higher than those of patients with any other uveitis etiologies or healthy controls (P < 0.01).

Conclusions: SP-D may be a less invasive and less expensive laboratory examination for sarcoidosis screening. SP-D should be considered as a new laboratory parameter for the diagnosis of uveitis and sarcoidosis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1997 Apr 24;336(17):1224-34 - PubMed
    1. Int Ophthalmol Clin. 2002 Winter;42(1):143-50 - PubMed
    1. Int Ophthalmol Clin. 2002 Winter;42(1):99-103 - PubMed
    1. Am J Physiol Lung Cell Mol Physiol. 2006 May;290(5):L1010-7 - PubMed
    1. Acta Ophthalmol. 2009 Jun;87(4):424-8 - PubMed

Substances